{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:41:31Z","timestamp":1777574491756,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thoracic.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thoracic Surgery Clinics"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.thorsurg.2024.11.009","type":"journal-article","created":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T11:04:51Z","timestamp":1734865491000},"page":"155-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hybrid Approaches to Local Management of Pulmonary Metastatic Disease"],"prefix":"10.1016","volume":"35","author":[{"given":"Ngoc-Quynh","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orly","family":"Yariv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Sihag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thorsurg.2024.11.009_bib1","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jtcvs.2010.08.089","article-title":"Safety distance in the resection of colorectal lung metastases: a prospective evaluation of satellite tumor cells with immunohistochemistry","volume":"141","author":"Welter","year":"2011","journal-title":"J\u00a0Thorac Cardiothorac Surg"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib2","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/hed.23232","article-title":"Survival impact of pulmonary metastasectomy for patients with head and neck cancer","volume":"35","author":"Miyazaki","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib3","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.21037\/jtd.2019.05.12","article-title":"Impact of resection margin length and tumor depth on the local recurrence after thoracoscopic pulmonary wedge resection of a single colorectal metastasis","volume":"11","author":"Chung","year":"2019","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib4","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/ejcts\/ezaa405","article-title":"Report from the European Society of Thoracic Surgeons database 2019: current surgical practice and perioperative outcomes of pulmonary metastasectomy","volume":"59","author":"Gonzalez","year":"2021","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"2","key":"10.1016\/j.thorsurg.2024.11.009_bib5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.athoracsur.2018.10.028","article-title":"Expert consensus document on pulmonary metastasectomy","volume":"107","author":"Handy","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-5223(97)70397-0","article-title":"Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases","volume":"113","author":"Pastorino","year":"1997","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.athoracsur.2014.04.063","article-title":"Thoracoscopic or open surgery for pulmonary metastasectomy: an observer blinded study","volume":"98","author":"Eckardt","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/icvts\/ivv337","article-title":"Is manual palpation of the lung necessary in patients undergoing pulmonary metastasectomy?","volume":"22","author":"Macherey","year":"2016","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jso.23450","article-title":"Pulmonary metastasectomy","volume":"109","author":"Ripley","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/icvts\/ivt300","article-title":"Is a thoracotomy rather than thoracoscopic resection associated with improved survival after pulmonary metastasectomy?","volume":"17","author":"Greenwood","year":"2013","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.thorsurg.2016.04.004","article-title":"Lymph node dissection and pulmonary metastasectomy","volume":"26","author":"Sihag","year":"2016","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib12","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0003-4975(03)01200-1","article-title":"Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma","volume":"77","author":"Ercan","year":"2004","journal-title":"Ann Thorac Surg"},{"issue":"12","key":"10.1016\/j.thorsurg.2024.11.009_bib13","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.21037\/jtd-23-769","article-title":"Prognostic significance of lymph nodes assessment during pulmonary metastasectomy: a systemic review and meta-analysis","volume":"15","author":"Minervini","year":"2023","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib14","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1148\/radiol.2431060088","article-title":"Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients","volume":"243","author":"Simon","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/annonc\/mdv037","article-title":"Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases","volume":"26","author":"de Baere","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1148\/radiol.11101643","article-title":"Microwave ablation therapy: clinical utility in treatment of pulmonary metastases","volume":"261","author":"Vogl","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib18","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1097\/01.RVI.0000094584.83406.3e","article-title":"Society of Interventional Radiology clinical practice guidelines","volume":"14","author":"Sacks","year":"2003","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib19","doi-asserted-by":"crossref","first-page":"W581","DOI":"10.2214\/AJR.11.7536","article-title":"Ablation for the management of pulmonary malignancies","volume":"197","author":"Sofocleous","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2214\/AJR.17.18368","article-title":"The role of percutaneous image-guided thermal ablation for the treatment of pulmonary malignancies","volume":"209","author":"Mouli","year":"2017","journal-title":"AJR Am J Roentgenol"},{"issue":"10422","key":"10.1016\/j.thorsurg.2024.11.009_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(23)01857-3","volume":"403","author":"Tsai","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.thorsurg.2024.11.009_bib22","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ijrobp.2013.11.010","article-title":"Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib","volume":"88","author":"Gan","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"34","key":"10.1016\/j.thorsurg.2024.11.009_bib23","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1200\/JCO.2014.56.7412","article-title":"Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer","volume":"32","author":"Iyengar","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.thorsurg.2024.11.009_bib24","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/COC.0b013e31822dfd13","article-title":"Noninferiority trials in second-line treatments of nonsmall cell lung cancer: a systematic review of literature with meta-analysis of phase III randomized clinical trials","volume":"35","author":"Tassinari","year":"2012","journal-title":"Am J Clin Oncol"},{"issue":"24","key":"10.1016\/j.thorsurg.2024.11.009_bib25","first-page":"03281","article-title":"Stereotactic ablative radiation for oligoprogressive cancers: results of the randomized phase 2 STOP trial","volume":"S0360-3016","author":"Schellenberg","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.thorsurg.2024.11.009_bib26","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/j.cllc.2020.05.025","article-title":"Salvage stereotactic body radiation therapy for isolated local recurrence after primary surgical resection of non-small-cell lung cancer","volume":"22","author":"Sittenfeld","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","article-title":"Oligometastases revisited","volume":"8","author":"Weichselbaum","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib29","first-page":"1677","article-title":"Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment","volume":"25","author":"Mehta","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib30","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ijrobp.2014.04.007","article-title":"Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer","volume":"89","author":"Parikh","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fonc.2017.00210","article-title":"Radiotherapy for oligometastatic lung cancer","volume":"7","author":"Bergsma","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cllc.2014.04.003","article-title":"An individual patient data metaanalysis ofoutcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer","volume":"15","author":"Ashworth","year":"2014","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib33","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/JTO.0000000000000673","article-title":"The IASLC Lung Cancer Staging Project: proposals for the revision of the Mdescriptors in the forthcoming eighth edition of the TNM classification of lung cancer","volume":"10","author":"Eberhardt","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib34","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib35","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.jtho.2019.05.037","article-title":"Defining synchronous oligometastatic non-small cell lung cancer: a systematic review","volume":"14","author":"Giaj-Levra","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib36","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.jtho.2019.07.025","article-title":"Definition of synchronous oligometastatic non-small cell lung cancer-A consensus report","volume":"14","author":"Dingemans","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"issue":"3","key":"10.1016\/j.thorsurg.2024.11.009_bib37","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jtcvs.2021.04.090","article-title":"The emerging role of local therapy in oligometastatic non-small cell lung cancer","volume":"163","author":"Isbell","year":"2021","journal-title":"J\u00a0Thorac and Cardiovasc Surgery"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib38","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-15-0822","article-title":"New strategies in stereotactic radiotherapy for oligometastases","volume":"21","author":"Palma","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib39","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-5223(19)40289-4","article-title":"Multiple primary lung cancers","volume":"70","author":"Martini","year":"1975","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib40","doi-asserted-by":"crossref","first-page":"13200","DOI":"10.1038\/ncomms13200","article-title":"Genomic heterogeneity of multiple synchronous lung cancer","volume":"7","author":"Liu","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib41","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1183\/09031936.00105911","article-title":"Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy","volume":"39","author":"Warth","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib42","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. Maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib43","doi-asserted-by":"crossref","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib44","first-page":"192","article-title":"Oligometastatic NSCLC: the changing role of surgery","volume":"3","author":"Valli\u00e8res","year":"2014","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5306\/wjco.v10.i10.318","article-title":"Management of oligometastatic non-small cell lung cancer patients: current controversies and future directions","volume":"10","author":"Cou\u00f1ago","year":"2019","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.thorsurg.2016.04.002","article-title":"Surgical management of oligometastatic non-small cell lung cancer","volume":"26","author":"Lanuti","year":"2016","journal-title":"Thorac Surg Clin"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib47","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/cncr.29134","article-title":"The rise in metastasectomy across cancer types over the past decade","volume":"121","author":"Bartlett","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib48","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.280.17.1485","article-title":"Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial","volume":"280","author":"Patchell","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib49","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s11748-016-0630-7","article-title":"Approach for oligometastasis in non-small cell lung cancer","volume":"64","author":"Suzuki","year":"2016","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib50","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jtcvs.2011.03.035","article-title":"Survival after resection of synchronous non-small cell lung cancer","volume":"142","author":"Fabian","year":"2011","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib51","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ejcts.2008.07.069","article-title":"Survival after resection of synchronous bilateral lung cancer","volume":"34","author":"De Leyn","year":"2008","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib52","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ejcts.2009.11.025","article-title":"Surgical treatment of synchronous multiple lung cancer located in a different lobe or lung: high survival in node-negative subgroup","volume":"37","author":"Voltolini","year":"2010","journal-title":"Eur J Cardio Thorac Surg"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12957-017-1105-8","article-title":"Surgical treatment in non-small cell lung cancer with pulmonary oligometastasis","volume":"15","author":"He","year":"2017","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib54","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jss.2023.10.025","article-title":"Surgery for M1a non-small cell lung cancer with additional pulmonary nodules in the contralateral lobe","volume":"295","author":"Kumar","year":"2024","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib55","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1200\/JCO.2008.19.6386","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for lung metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clon.2015.08.011","article-title":"Clinical outcome of stereotactic ablative body radiotherapy for lung metastatic lesions in non-small cell lung cancer oligometastatic patients","volume":"28","author":"De Rose","year":"2016","journal-title":"Clin Oncol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lungcan.2011.04.021","article-title":"Stereotactic body radiation therapy for lung metastases","volume":"75","author":"Ricardi","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib58","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00270-012-0340-1","article-title":"Cardiovascular and Interventional Radiological Society of Europe (CIRSE). Standards of practice: guidelines for thermal ablation of primary and secondary lung tumors","volume":"35","author":"Pereira","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12032-020-01361-1","article-title":"RFA of primary and metastatic lung tumors: long-term results","volume":"37","author":"Picchi","year":"2020","journal-title":"Med Oncol"},{"issue":"6","key":"10.1016\/j.thorsurg.2024.11.009_bib60","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/djac015","article-title":"Randomized trial of first-line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-mutated non-small cell lung cancer","volume":"115","author":"Wang","year":"2023","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"23","key":"10.1016\/j.thorsurg.2024.11.009_bib61","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","article-title":"First-line crizotinib versus chemotherapy in ALK-positive lung cancer","volume":"371","author":"Solomon","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.thorsurg.2024.11.009_bib62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.thorsurg.2024.11.009_bib63","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume":"13","author":"Rosell","year":"2012","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.thorsurg.2024.11.009_bib64","doi-asserted-by":"crossref","first-page":"e000168","DOI":"10.1136\/esmoopen-2017-000168","article-title":"Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma","volume":"2","author":"Patil","year":"2017","journal-title":"ESMO Open"},{"issue":"19","key":"10.1016\/j.thorsurg.2024.11.009_bib65","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"10183","key":"10.1016\/j.thorsurg.2024.11.009_bib66","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(18)32409-7","article-title":"Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial","volume":"393","author":"Mok","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.radonc.2019.01.001","article-title":"The METABANK score: a clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease","volume":"133","author":"Van den Begin","year":"2019","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.thorsurg.2024.11.009_bib68","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/02841860802662722","article-title":"Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis","volume":"48","author":"Rusthoven","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.thorsurg.2024.11.009_bib69","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lungcan.2017.03.010","article-title":"Patterns of initial and intracranial failure in metastatic EGFR-mutant non-small cell lung cancer treated with erlotinib","volume":"108","author":"Patel","year":"2017","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.thorsurg.2024.11.009_bib70","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/JTO.0000000000000648","article-title":"Pattern of failure analysis in metastatic EGFR-mutant lung cancer treated with tyrosine kinase inhibitors to identify candidates for consolidation stereotactic body radiation therapy","volume":"10","author":"Al-Halabi","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"issue":"12","key":"10.1016\/j.thorsurg.2024.11.009_bib71","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.thorsurg.2024.11.009_bib72","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jtho.2018.05.019","article-title":"Consolidative local ablative therapy improves the survival of patients with synchronous oligometastatic NSCLC harboring EGFR activating mutation treated with first-line EGFR-TKIs","volume":"13","author":"Xu","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"issue":"25","key":"10.1016\/j.thorsurg.2024.11.009_bib73","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Thoracic Surgery Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412724001166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412724001166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T11:39:04Z","timestamp":1750419544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547412724001166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1547412724001166"],"URL":"https:\/\/doi.org\/10.1016\/j.thorsurg.2024.11.009","relation":{},"ISSN":["1547-4127"],"issn-type":[{"value":"1547-4127","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hybrid Approaches to Local Management of Pulmonary Metastatic Disease","name":"articletitle","label":"Article Title"},{"value":"Thoracic Surgery Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thorsurg.2024.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}